Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 4847874, 9 pages
http://dx.doi.org/10.1155/2016/4847874
Research Article

HSP27 Inhibits Homocysteine-Induced Endothelial Apoptosis by Modulation of ROS Production and Mitochondrial Caspase-Dependent Apoptotic Pathway

1Department of Cardiology, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun 130041, China
2Department of Respiratory Medicine, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun 130041, China

Received 13 January 2016; Revised 18 March 2016; Accepted 23 March 2016

Academic Editor: Cheng I. Cheng

Copyright © 2016 Xin Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Glass and J. L. Witztum, “Atherosclerosis. The road ahead,” Cell, vol. 104, no. 4, pp. 503–516, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. G. K. Hansson, “Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1626–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-C. Guilland, A. Favier, G. Potier de Courcy, P. Galan, and S. Hercberg, “Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data,” Pathologie Biologie, vol. 51, no. 2, pp. 101–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. B. Lawrence de Koning, G. H. Werstuck, J. Zhou, and R. C. Austin, “Hyperhomocysteinemia and its role in the development of atherosclerosis,” Clinical Biochemistry, vol. 36, no. 6, pp. 431–441, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Clarke, L. Daly, K. Robinson et al., “Hyperhomocysteinemia: an independent risk factor for vascular disease,” The New England Journal of Medicine, vol. 324, no. 17, pp. 1149–1155, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Horvath, L. Szapary, L. Debreceni et al., “Effect of sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases,” Clinical Hemorheology and Microcirculation, vol. 42, no. 1, pp. 19–28, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Briasoulis, D. Tousoulis, E. S. Androulakis, N. Papageorgiou, G. Latsios, and C. Stefanadis, “Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches,” Recent Patents on Cardiovascular Drug Discovery, vol. 7, no. 1, pp. 21–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Davignon and P. Ganz, “Role of endothelial dysfunction in atherosclerosis,” Circulation, vol. 109, no. 23, pp. III27–III32, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. B.-J. Martin and T. J. Anderson, “Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction,” The Canadian Journal of Cardiology, vol. 25, pp. 15A–20A, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Chen, P. Eriksson, T. Kimura, I. Herzfeld, and G. Valen, “Apoptosis and angiogenesis are induced in the unstable coronary atherosclerotic plaque,” Coronary Artery Disease, vol. 16, no. 3, pp. 191–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. G. Concannon, A. M. Gorman, and A. Samali, “On the role of Hsp27 in regulating apoptosis,” Apoptosis, vol. 8, no. 1, pp. 61–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Salari, T. Seibert, Y.-X. Chen et al., “Extracellular HSP27 acts as a signaling molecule to activate NF-κB in macrophages,” Cell Stress & Chaperones, vol. 18, no. 1, pp. 53–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-F. Chen, L.-D. Xie, and C.-S. Xu, “Role of heat shock protein 27 phosphorylation in migration of vascular smooth muscle cells,” Molecular and Cellular Biochemistry, vol. 327, no. 1-2, pp. 1–6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. L. Martin-Ventura, M. C. Duran, L. M. Blanco-Colio et al., “Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis,” Circulation, vol. 110, no. 15, pp. 2216–2219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C. A. Efthymiou, M. M. Mocanu, J. de Belleroche, D. J. Wells, D. S. Latchmann, and D. M. Yellon, “Heat shock protein 27 protects the heart against myocardial infarction,” Basic Research in Cardiology, vol. 99, no. 6, pp. 392–394, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Miller, S. Poon, B. Hibbert, K. Rayner, Y.-X. Chen, and E. R. O'Brien, “Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 3, pp. e10–e14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Pandey, S. Saini, R. Khatoon, D. Sharma, G. Narayan, and D. Kar Chowdhuri, “Overexpression of hsp27 rescued neuronal cell death and reduction in life- and health-span in drosophila melanogaster against prolonged exposure to dichlorvos,” Molecular Neurobiology, 2015. View at Publisher · View at Google Scholar
  18. B. Zhang, H. S. Zhou, Q. Cheng, L. Lei, and B. Hu, “Overexpression of HSP27 in cultured human aortic smooth muscular cells reduces apoptosis induced by low-frequency and low-energy ultrasound by inhibition of an intrinsic pathway,” Genetics and Molecular Research, vol. 12, no. 4, pp. 6588–6601, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Korngut, C. H. E. Ma, J. A. Martinez et al., “Overexpression of human HSP27 protects sensory neurons from diabetes,” Neurobiology of Disease, vol. 47, no. 3, pp. 436–443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Kubisch, M. J. Dimagno, A. B. Tietz et al., “Overexpression of heat shock protein Hsp27 protects against cerulein-induced pancreatitis,” Gastroenterology, vol. 127, no. 1, pp. 275–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Wyttenbach, O. Sauvageot, J. Carmichael, C. Diaz-Latoud, A.-P. Arrigo, and D. C. Rubinsztein, “Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin,” Human Molecular Genetics, vol. 11, no. 9, pp. 1137–1151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. A.-P. Arrigo, S. Virot, S. Chaufour, W. Firdaus, C. Kretz-Remy, and C. Diaz-Latoud, “Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels,” Antioxidants & Redox Signaling, vol. 7, no. 3-4, pp. 414–424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Pandey, R. Farber, A. Nakazawa et al., “Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3,” Oncogene, vol. 19, no. 16, pp. 1975–1981, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. C. G. Concannon, S. Orrenius, and A. Samali, “Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c,” Gene Expression, vol. 9, no. 4-5, pp. 195–201, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. N. R. Madamanchi, S. Li, C. Patterson, and M. S. Runge, “Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 3, pp. 321–326, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. P. L. Huang, “Endothelial nitric oxide synthase and endothelial dysfunction,” Current Hypertension Reports, vol. 5, no. 6, pp. 473–480, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. L. Bourque, S. T. Davidge, and M. A. Adams, “The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 300, no. 6, pp. R1288–R1295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Takahashi, “Inflammatory cytokines in the pathogenesis of atherosclerosis,” Nihon Rinsho. Japanese Journal of Clinical Medicine, vol. 69, no. 1, pp. 30–33, 2011. View at Google Scholar · View at Scopus
  29. P. J. Little, A. Chait, and A. Bobik, “Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis,” Pharmacology and Therapeutics, vol. 131, no. 3, pp. 255–268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. H.-P. Zhang, F.-L. Zheng, J.-H. Zhao, D.-X. Guo, and X.-L. Chen, “Genistein inhibits ox-ldl-induced vcam-1, icam-1 and mcp-1 expression of huvecs through heme oxygenase-1,” Archives of Medical Research, vol. 44, no. 1, pp. 13–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Lu, X. Zhu, G.-X. Liang et al., “Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells,” Amino Acids, vol. 43, no. 5, pp. 2125–2136, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Clutton, “The importance of oxidative stress in apoptosis,” British Medical Bulletin, vol. 53, no. 3, pp. 662–668, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Frenzel, F. Grespi, W. Chmelewskij, and A. Villunger, “Bcl2 family proteins in carcinogenesis and the treatment of cancer,” Apoptosis, vol. 14, no. 4, pp. 584–596, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. F. M. Faraci and S. R. Lentz, “Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction,” Stroke, vol. 35, no. 2, pp. 345–347, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. K. S. Woo, M. Qiao, P. Chook et al., “Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention,” Journal of Cardiac Surgery, vol. 17, no. 5, pp. 432–435, 2002. View at Google Scholar · View at Scopus
  36. C. Garrido, E. Schmitt, C. Candé, N. Vahsen, A. Parcellier, and G. Kroemer, “HSP27 and HSP70: potentially oncogenic apoptosis inhibitors,” Cell Cycle, vol. 2, no. 6, pp. 579–584, 2003. View at Google Scholar · View at Scopus
  37. M. de Graauw, I. Tijdens, R. Cramer, S. Corless, J. F. Timms, and B. van de Water, “Heat shock protein 27 is the major differentially phosphorylated protein involved in renal epithelial cellular stress response and controls focal adhesion organization and apoptosis,” The Journal of Biological Chemistry, vol. 280, no. 33, pp. 29885–29898, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Higashi, K. Noma, M. Yoshizumi, and Y. Kihara, “Endothelial function and oxidative stress in cardiovascular diseases,” Circulation Journal, vol. 73, no. 3, pp. 411–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Lerman, D. R. Holmes Jr., M. R. Bell, K. N. Garratt, R. A. Nishimura, and J. C. Burnett Jr., “Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans,” Circulation, vol. 92, no. 9, pp. 2426–2431, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Zakynthinos and N. Pappa, “Inflammatory biomarkers in coronary artery disease,” Journal of Cardiology, vol. 53, no. 3, pp. 317–333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. A. Doggrell, “The endothelin system and its role in acute myocardial infarction,” Expert Opinion on Therapeutic Targets, vol. 8, no. 3, pp. 191–201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. R. H. Eibl and M. Benoit, “Molecular resolution of cell adhesion forces,” IEE Proceedings Nanobiotechnology, vol. 151, no. 3, pp. 128–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Cai and D. G. Harrison, “Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress,” Circulation Research, vol. 87, no. 10, pp. 840–844, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. F. de Nigris, A. Lerman, L. J. Ignarro et al., “Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis,” Trends in Molecular Medicine, vol. 9, no. 8, pp. 351–359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. A. F. G. Slater, C. Stefan, I. Nobel, D. J. van den Dobbelsteen, and S. Orrenius, “Signalling mechanisms and oxidative stress in apoptosis,” Toxicology Letters, vol. 82-83, pp. 149–153, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. J. J. Lemasters, “V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis,” The American Journal of Physiology, vol. 276, no. 1, pp. G1–G6, 1999. View at Google Scholar · View at Scopus
  47. A. G. Porter and R. U. Jänicke, “Emerging roles of caspase-3 in apoptosis,” Cell Death and Differentiation, vol. 6, no. 2, pp. 99–104, 1999. View at Publisher · View at Google Scholar · View at Scopus